One of the main advantages this compound has over native IGF-1 is that it actively circulates in the body for a longer period of time and by some measures is up to ten times as potent
Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease): a systematic review and meta-analysis
It is commonly prescribed to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and to treat or prevent deep vein thrombosis (DVT) and pulmonary embolism (PE)
Zhou N, Hofstetter WL , Working Group ESCC, Mitchell KG, Bayley EM, Ajani JA, Antonoff MB, Betancourt SL, Blum-Murphy M, Feldman HA, Lin SH, Maru DM, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Weston BR
Cell Death Dis 10(3):245